Difference between revisions of "Part:BBa K5398610"

 
(94 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
<partinfo>BBa_K5398600 short</partinfo>
+
<partinfo>BBa_K5398610 short</partinfo>
 
__TOC__
 
__TOC__
 
===Introduction===
 
===Introduction===
Tyrosinase is a copper-containing oxidoreductase that possesses two catalytic activities, and is involved in the first few steps of melanin synthesis from l-tyrosine. As shown in Fig. 1, tyrosinase catalyzes the ortho-hydroxylation of l-tyrosine to l-DOPA via its monophenolase (MP) activity, and consecutively oxidizes l-DOPA to l-dopaquinone via the diphenolase (DP) activity, thereby consuming oxygen. l-dopaquinone is not stable and will be further non-enzymatically oxidized to l-dopachrome (a red-colored product) in the presence of O2.TyrVs refers to a tyrosinase enzyme derived from Verrucomicrobium spinosum, which plays a critical role in the hydroxylation of tyrosine residues into L-Dopa. This enzyme has shown efficient activity, particularly in the context of biological adhesion, as demonstrated in studies co-expressing mussel foot protein 3 with TyrVs.
+
Tyrosinase is a copper-containing oxidoreductase that possesses two catalytic activities, and is involved in the first few steps of melanin synthesis from l-tyrosine. As shown in Fig. 1, tyrosinase catalyzes the ortho-hydroxylation of l-tyrosine to L-DOPA via its monophenolase (MP) activity, and consecutively oxidizes L-DOPA to l-dopaquinone via the diphenolase (DP) activity, thereby consuming oxygen. l-dopaquinone is not stable and will be further non-enzymatically oxidized to l-dopachrome (a red-colored product) in the presence of O<sub>2</sub>.TyrVs refers to a tyrosinase enzyme derived from Verrucomicrobium spinosum, which plays a critical role in the hydroxylation of tyrosine residues into L-Dopa. This enzyme has shown efficient activity, particularly in the context of biological adhesion, as demonstrated in studies co-expressing mussel foot protein 3 with TyrVs.
</p>
+
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 22: Line 21:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/.webp" width="400" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/design/design-new/part-fig1.png" width="800" height="auto" alt="Protein purification">
 
         <p><b>Fig. 1 | Synthesis scheme of L-DOPA and further oxidized product L-dopachrome.</b></p>
 
         <p><b>Fig. 1 | Synthesis scheme of L-DOPA and further oxidized product L-dopachrome.</b></p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
===Usage and Biology===
 
===Usage and Biology===
 
In our project, TyrVs can catalyze the tyrosine residues in the TRn4-mfp5 protein, converting them into L-DOPA, thereby enhancing its adhesive properties. L-DOPA exhibits excellent adhesion, particularly in moist environments. This transformation process is similar to the mechanism used by marine organisms like mussels, which enhance their adhesion through L-DOPA.
 
In our project, TyrVs can catalyze the tyrosine residues in the TRn4-mfp5 protein, converting them into L-DOPA, thereby enhancing its adhesive properties. L-DOPA exhibits excellent adhesion, particularly in moist environments. This transformation process is similar to the mechanism used by marine organisms like mussels, which enhance their adhesion through L-DOPA.
 
===Characterization===
 
===Characterization===
====Plasmid Construction====
+
====Plasmid construction====
We considered cloning TyrVs into the pET-PC-SUMO vector to explore the potential for enhancing its expression level. We constructed the pET-PC-SUMO-TyrVs vector and transformed it into <i>E. coli</i>BL21(DE3).
+
We considered cloning TyrVs into the pET-PC-SUMO vector to explore the potential for enhancing its expression level. We constructed the pET-PC-SUMO-TyrVs vector and transformed it into <i>E.coli</i> BL21(DE3).
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 49: Line 49:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/sumo-tyrvs.webp" width="400" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/sumo-tyrvs.webp" width="800" height="auto" alt="Protein purification">
 
         <p><b>Fig. 2 | Plasmid pET-PC-SUMO-TyrVs construction results.</b></p>
 
         <p><b>Fig. 2 | Plasmid pET-PC-SUMO-TyrVs construction results.</b></p>
<p>a.Expression plasmids of TyrVs. b.PCR results of pET-PC-SUMO-TyrVs. Line 1: Marker. Lines 2-3:Vector;Lines 4-5:Gene.</p>
+
<p><b>a.</b>Expression plasmids of TyrVs. <b>b.</b>PCR results of pET-PC-SUMO-TyrVs. Line 1: Marker; Lines 2,3:Vector; Lines 4,5:Gene.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
====Protein expression====
 
====Protein expression====
a single colony  
+
A single colony from a freshly streaked plate of the cells was cultured in 5 mL of LB  
from a freshly streaked plate of the cells was cultured in 5 mL of LB  
+
 
medium with 25 μg/mL Ampicillin at 37℃ overnight. The secondary  
 
medium with 25 μg/mL Ampicillin at 37℃ overnight. The secondary  
 
cultures were prepared with 1% inoculum in 50 mL of LB medium with 25 μg/mL Ampicillin. Cultures were  
 
cultures were prepared with 1% inoculum in 50 mL of LB medium with 25 μg/mL Ampicillin. Cultures were  
Line 63: Line 63:
 
(OD<sub>600</sub>) reached 0.6–0.8. 1 mM IPTG was added to induce production of recombinant proteins and  
 
(OD<sub>600</sub>) reached 0.6–0.8. 1 mM IPTG was added to induce production of recombinant proteins and  
 
cultures were further cultivated at 16℃ and 200 rpm for 20 h. The cells  
 
cultures were further cultivated at 16℃ and 200 rpm for 20 h. The cells  
were collected by centrifugation at 6000 ×g at 4℃ for 20 min.The recombinant cells were harvested by centrifugation and re-suspension in lysis buffer(10 mM imidazole, 50 mM Tris-HCl, 500 mM NaCl, pH 8.0)and lysed on ice by sonication.Sonicated samples were centrifuged at 12,000 ×g at 4 ◦C for 20 min to obtain insoluble and soluble fractions.After protein extraction, different proteins were separated by SDS-PAGE and stained with Coomassie Brilliant Blue.  
+
were collected by centrifugation at 6000×<i>g</i> at 4℃ for 20 min.The recombinant cells were harvested by centrifugation and re-suspension in lysis buffer(10 mM imidazole, 50 mM Tris-HCl, 500 mM NaCl, pH 8.0)and lysed on ice by sonication.Sonicated samples were centrifuged at 12,000×<i>g</i> at 4 for 20 min to obtain insoluble and soluble fractions. After protein extraction, different proteins were separated by SDS-PAGE and stained with Coomassie Brilliant Blue.  
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 82: Line 82:
 
     <div class="module">
 
     <div class="module">
 
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-pre-expression.webp" width="400" height="auto" alt="Protein purification">
 
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-pre-expression.webp" width="400" height="auto" alt="Protein purification">
         <p><b>Fig. 3 | Expression of recombinant TyrVs in <i>E. coli</i>BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p>
+
         <p><b>Fig. 3 | Expression of recombinant TyrVs in <i>E.coli</i> BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p>
<p>Lane 1: Marker. lanes 2 to 4: whole-cell lysate, supernatant and pellet from induced cells with 0.5 mM IPTG respectively;lanes 5 to 7: whole-cell lysate, supernatant and pellet from induced cells respectively.</p>
+
<p>Lane 1: Marker; lanes 2-4: whole-cell lysate, supernatant and pellet from induced cells with 0.5 mM IPTG respectively; lanes 5-7: whole-cell lysate, supernatant and pellet from induced cells respectively.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
====Western blotting====
 
====Western blotting====
 
Western bolotting revealed that after induction with IPTG, TyrVs was primarily expressed in its soluble form.
 
Western bolotting revealed that after induction with IPTG, TyrVs was primarily expressed in its soluble form.
Line 107: Line 108:
 
     <div class="module">
 
     <div class="module">
 
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-western.webp" width="300" height="auto" alt="Protein purification">
 
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-western.webp" width="300" height="auto" alt="Protein purification">
         <p><b>Fig. 4 | Western blotting analysis recombinant TyrVs in <i>E. coli</i>BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p>
+
         <p><b>Fig. 4 | Western blotting analysis recombinant TyrVs in <i>E.coli</i> BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p>
<p> Lane 1-3:whole-cell lysate,pellet and supernatant from induced cells with 0.5 mM IPTG respectively.</p>
+
<p> Lanes 1-3: whole-cell lysate,pellet and supernatant from induced cells with 0.5 mM IPTG respectively.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
Line 130: Line 131:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/mizuo-tyrvs.webp" width="400" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/sumo-tyrvs-mizuo-new.webp" width="400" height="auto" alt="Protein purification">
 
         <p><b>Fig. 5 | SDS-PAGE analysis of protein fractions eluted from the Ni-NTA column.</b></p>
 
         <p><b>Fig. 5 | SDS-PAGE analysis of protein fractions eluted from the Ni-NTA column.</b></p>
<p>Lane 1: Marker. Lane 2: Lysis Buffer. Lane 3: Supernatant. Lane 4: 20 mM Imidazole. Lane 5: 50 mM Imidazole. Lane 6: 150 mM Imidazole. </p>
+
<p>Lane 1: Marker; Lane 2: Lysis Buffer; Lane 3: Supernatant; Lane 4: 20 mM Imidazole; Lane 5: 50 mM Imidazole; Lane 6: 150 mM Imidazole. </p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
====Enzyme activity test====
 
====Enzyme activity test====
We dialyzed the extracted SUMO-TyrVs for 24 hours, followed by diluting it 10,000-fold for enzymatic activity assays. In a 96 Well Cell Culture Plates, we prepared different concentrations of tyrosine and L-DOPA solution, added the diluted SUMO-TyrVs, and measured the change in OD475 over the first 5 minutes using a microplate reader.  
+
We dialyzed the extracted SUMO-TyrVs for 24 h, followed by diluting it 10,000-fold for enzymatic activity assays. In a 96 Well Cell Culture Plates, we prepared different concentrations of tyrosine and L-DOPA solution, added the diluted SUMO-TyrVs, and measured the change in OD<sub>475</sub> over the first 5 min using a microplate reader.  
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 155: Line 157:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-96.webp" width="400" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-96.webp" width="800" height="auto" alt="Protein purification">
 
         <p><b>Fig. 6 | The 96 Well Cell Culture Plates of tyrosinase TyrVs.</b></p>
 
         <p><b>Fig. 6 | The 96 Well Cell Culture Plates of tyrosinase TyrVs.</b></p>
<p>a.The experiment of enzymatic reaction from tyrosine to dopaquinone. b.The experiment of enzymatic reaction from L-DOPA to dopaquinone. </p>
+
<p><b>a.</b>The experiment of enzymatic reaction from tyrosine to dopaquinone. <b>b.</b>The experiment of enzymatic reaction from L-DOPA to dopaquinone. </p>
 
     </div>
 
     </div>
 
</body>
 
</body>
Line 179: Line 181:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/new-abcd.webp" width="400" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/new-abcd.webp" width="600" height="auto" alt="Protein purification">
 
         <p><b>Fig. 7 | The activity assay results of tyrosinase TyrVs</b></p>
 
         <p><b>Fig. 7 | The activity assay results of tyrosinase TyrVs</b></p>
<p>a-b.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from tyrosine to dopaquinone experiments. c-d.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from L-DOPA to dopaquinone experiments. </p>
+
<p><b>a-b.</b>Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from tyrosine to dopaquinone experiments. <b>c-d.</b>Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from L-DOPA to dopaquinone experiments. </p>
 +
    </div>
 +
</body>
 +
</html>
 +
 
 +
====Mathematical modeling analysis====
 +
Tyrosinase exhibits dual catalytic properties, capable of catalyzing the conversion of tyrosine to L-DOPA and L-DOPA to dopaquinone. We analyzed through mathematical modeling to determine how to maximize the oxidation of tyrosine to L-DOPA. We selected multiple sets of parameters for fitting, and the goodness of fit R<sup>2</sup> was 0.9962, indicating a good fitting effect. We incorporated appropriate fitting parameters into the established model and determined that the optimal reaction time is approximately 130 sec, at which point the production of L-DOPA reaches its peak. To demonstrate that the reaction can proceed stably under conventional conditions, we introduced perturbations in each reaction channel.Under different disturbance conditions, the trend of dopamine quantity changes is similar, and the yield fluctuation is small, our reaction system has strong environmental adaptability and stability.
 +
<html lang="zh">
 +
<head>
 +
    <meta charset="UTF-8">
 +
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
 +
    <style>
 +
        .module {
 +
            border: 1px solid #ccc; /* 边框 */
 +
            padding: 20px; /* 内边距 */
 +
            margin: 20px auto; /* 外边距,自动居中 */
 +
            width: 800px; /* 模块宽度 */
 +
            text-align: center; /* 内容居中 */
 +
            box-shadow: 0px 0px 10px rgba(0, 0, 0, 0.1); /* 阴影效果 */
 +
        }
 +
  </style>
 +
</head>
 +
<body>
 +
    <div class="module">
 +
        <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/model.webp" width="800" height="auto" alt="Protein purification">
 +
        <p><b>Fig. 8 | The activity assay results of tyrosinase TyrVs</b></p>
 +
<p><b>a.</b>Data fitting results. <b>b.</b>Changes in the concentrations of various substances in the reaction system. <b>c.</b>Changes in the concentration of substances in the system after adding disturbances.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
Line 187: Line 215:
 
<br><br><br><br>
 
<br><br><br><br>
  
 
 
 
 
 
=== Reference ===
 
 
<br>#TAN D, ZHAO J P, RAN G Q, et al. Highly efficient biocatalytic synthesis of L-DOPA using in situ immobilized <em>Verrucomicrobium spinosum</em> tyrosinase on polyhydroxyalkanoate nano-granules [J]. <em>Appl. Microbiol. Biotechnol.</em>, 2019, 103(14): 5663-78.
 
<br>#YAO L, WANG X, XUE R, et al. Comparative analysis of mussel foot protein 3B co-expressed with tyrosinases provides a potential adhesive biomaterial [J]. <em>Int. J. Biol. Macromol.</em>, 2022, 195: 229-36.
 
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
Line 202: Line 221:
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
<partinfo>BBa_K5398600 SequenceAndFeatures</partinfo>
+
<partinfo>BBa_K5398610 SequenceAndFeatures</partinfo>
  
 
+
=== Reference ===
<!-- Uncomment this to enable Functional Parameter display
+
<p>[1]TAN D, ZHAO J P, RAN G Q, et al. Highly efficient biocatalytic synthesis of L-DOPA using in situ immobilized <em>Verrucomicrobium spinosum</em> tyrosinase on polyhydroxyalkanoate nano-granules [J]. <i>Appl. Microbiol. Biotechnol.</i>, 2019, 103(14): 5663-78.</p>
===Functional Parameters===
+
<p>[2]YAO L, WANG X, XUE R, et al. Comparative analysis of mussel foot protein 3B co-expressed with tyrosinases provides a potential adhesive biomaterial [J]. <i>Int. J. Biol. Macromol.</i>, 2022, 195: 229-36.</p>
<partinfo>BBa_K5398600 parameters</partinfo>
+
<!-- -->
+

Latest revision as of 10:11, 2 October 2024

pET-PC-SUMO-TyrVs

Introduction

Tyrosinase is a copper-containing oxidoreductase that possesses two catalytic activities, and is involved in the first few steps of melanin synthesis from l-tyrosine. As shown in Fig. 1, tyrosinase catalyzes the ortho-hydroxylation of l-tyrosine to L-DOPA via its monophenolase (MP) activity, and consecutively oxidizes L-DOPA to l-dopaquinone via the diphenolase (DP) activity, thereby consuming oxygen. l-dopaquinone is not stable and will be further non-enzymatically oxidized to l-dopachrome (a red-colored product) in the presence of O2.TyrVs refers to a tyrosinase enzyme derived from Verrucomicrobium spinosum, which plays a critical role in the hydroxylation of tyrosine residues into L-Dopa. This enzyme has shown efficient activity, particularly in the context of biological adhesion, as demonstrated in studies co-expressing mussel foot protein 3 with TyrVs.

Protein purification

Fig. 1 | Synthesis scheme of L-DOPA and further oxidized product L-dopachrome.

Usage and Biology

In our project, TyrVs can catalyze the tyrosine residues in the TRn4-mfp5 protein, converting them into L-DOPA, thereby enhancing its adhesive properties. L-DOPA exhibits excellent adhesion, particularly in moist environments. This transformation process is similar to the mechanism used by marine organisms like mussels, which enhance their adhesion through L-DOPA.

Characterization

Plasmid construction

We considered cloning TyrVs into the pET-PC-SUMO vector to explore the potential for enhancing its expression level. We constructed the pET-PC-SUMO-TyrVs vector and transformed it into E.coli BL21(DE3).

Protein purification

Fig. 2 | Plasmid pET-PC-SUMO-TyrVs construction results.

a.Expression plasmids of TyrVs. b.PCR results of pET-PC-SUMO-TyrVs. Line 1: Marker; Lines 2,3:Vector; Lines 4,5:Gene.

Protein expression

A single colony from a freshly streaked plate of the cells was cultured in 5 mL of LB medium with 25 μg/mL Ampicillin at 37℃ overnight. The secondary cultures were prepared with 1% inoculum in 50 mL of LB medium with 25 μg/mL Ampicillin. Cultures were then incubated at 37℃ and 200 rpm until the optical density at 600 nm (OD600) reached 0.6–0.8. 1 mM IPTG was added to induce production of recombinant proteins and cultures were further cultivated at 16℃ and 200 rpm for 20 h. The cells were collected by centrifugation at 6000×g at 4℃ for 20 min.The recombinant cells were harvested by centrifugation and re-suspension in lysis buffer(10 mM imidazole, 50 mM Tris-HCl, 500 mM NaCl, pH 8.0)and lysed on ice by sonication.Sonicated samples were centrifuged at 12,000×g at 4 ℃ for 20 min to obtain insoluble and soluble fractions. After protein extraction, different proteins were separated by SDS-PAGE and stained with Coomassie Brilliant Blue.

Protein purification

Fig. 3 | Expression of recombinant TyrVs in E.coli BL21 (DE3) with pET-PC-SUMO-TyrVs.

Lane 1: Marker; lanes 2-4: whole-cell lysate, supernatant and pellet from induced cells with 0.5 mM IPTG respectively; lanes 5-7: whole-cell lysate, supernatant and pellet from induced cells respectively.

Western blotting

Western bolotting revealed that after induction with IPTG, TyrVs was primarily expressed in its soluble form.

Protein purification

Fig. 4 | Western blotting analysis recombinant TyrVs in E.coli BL21 (DE3) with pET-PC-SUMO-TyrVs.

Lanes 1-3: whole-cell lysate,pellet and supernatant from induced cells with 0.5 mM IPTG respectively.

We purified SUMO-TyrVs using a HiTrap Ni-NTA column. The purified protein was verified by SDS-PAGE and was found to be present in the 50 mM imidazole elution fraction.
Protein purification

Fig. 5 | SDS-PAGE analysis of protein fractions eluted from the Ni-NTA column.

Lane 1: Marker; Lane 2: Lysis Buffer; Lane 3: Supernatant; Lane 4: 20 mM Imidazole; Lane 5: 50 mM Imidazole; Lane 6: 150 mM Imidazole.

Enzyme activity test

We dialyzed the extracted SUMO-TyrVs for 24 h, followed by diluting it 10,000-fold for enzymatic activity assays. In a 96 Well Cell Culture Plates, we prepared different concentrations of tyrosine and L-DOPA solution, added the diluted SUMO-TyrVs, and measured the change in OD475 over the first 5 min using a microplate reader.

Protein purification

Fig. 6 | The 96 Well Cell Culture Plates of tyrosinase TyrVs.

a.The experiment of enzymatic reaction from tyrosine to dopaquinone. b.The experiment of enzymatic reaction from L-DOPA to dopaquinone.

The data were processed to generate a Michaelis-Menten curve and a Lineweaver-Burk plot. The experiment of enzymatic reaction from tyrosine to dopaquinone was conducted at 37°C with an enzyme concentration of 0.1 μg/mL. The calculated Michaelis constant (Km) and maximum velocity (Vmax) were 456.8 μmol/L and 0.31 μmol·L-1·s-1, respectively. The experiment of enzymatic reaction from L-DOPA to dopaquinone was conducted at 37°C with an enzyme concentration of 0.2 μg/mL. The calculated Michaelis constant (Km) and maximum velocity (Vmax) were 8787 μmol/L and 0.86 μmol·L-1·s-1, respectively.
Protein purification

Fig. 7 | The activity assay results of tyrosinase TyrVs

a-b.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from tyrosine to dopaquinone experiments. c-d.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from L-DOPA to dopaquinone experiments.

Mathematical modeling analysis

Tyrosinase exhibits dual catalytic properties, capable of catalyzing the conversion of tyrosine to L-DOPA and L-DOPA to dopaquinone. We analyzed through mathematical modeling to determine how to maximize the oxidation of tyrosine to L-DOPA. We selected multiple sets of parameters for fitting, and the goodness of fit R2 was 0.9962, indicating a good fitting effect. We incorporated appropriate fitting parameters into the established model and determined that the optimal reaction time is approximately 130 sec, at which point the production of L-DOPA reaches its peak. To demonstrate that the reaction can proceed stably under conventional conditions, we introduced perturbations in each reaction channel.Under different disturbance conditions, the trend of dopamine quantity changes is similar, and the yield fluctuation is small, our reaction system has strong environmental adaptability and stability.

Protein purification

Fig. 8 | The activity assay results of tyrosinase TyrVs

a.Data fitting results. b.Changes in the concentrations of various substances in the reaction system. c.Changes in the concentration of substances in the system after adding disturbances.






Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 1418
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 174
    Illegal BamHI site found at 708
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Reference

[1]TAN D, ZHAO J P, RAN G Q, et al. Highly efficient biocatalytic synthesis of L-DOPA using in situ immobilized Verrucomicrobium spinosum tyrosinase on polyhydroxyalkanoate nano-granules [J]. Appl. Microbiol. Biotechnol., 2019, 103(14): 5663-78.

[2]YAO L, WANG X, XUE R, et al. Comparative analysis of mussel foot protein 3B co-expressed with tyrosinases provides a potential adhesive biomaterial [J]. Int. J. Biol. Macromol., 2022, 195: 229-36.